Trial Profile
CUSTOM-V
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 26 Oct 2007
Price :
$35
*
At a glance
- Drugs Umirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Registrational; Therapeutic Use
- Acronyms CUSTOM-V
- Sponsors Xtent
- 26 Oct 2007 New trial record.